Compare · MSAC vs PNTM
MSAC vs PNTM
Side-by-side comparison of Medicus Sciences Acquisition Corp. (MSAC) and Pontem Corporation (PNTM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MSAC and PNTM operate in Blank Checks (Finance), so they compete in similar markets.
- PNTM is the larger of the two at $838.8M, about 7.5x MSAC ($112.4M).
Medicus Sciences Acquisition Corp.
Medicus Sciences Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on the healthcare industry primarily the medical technology sector in the United States and internationally. The company was incorporated in 2020 and is based in New York, New York.
Pontem Corporation
Pontem Corporation does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Latest MSAC
- SEC Form SC 13G/A filed by Medicus Sciences Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Medicus Sciences Acquisition Corp. (Amendment)
- SEC Form 15-12G filed by Medicus Sciences Acquisition Corp.
- SEC Form 25-NSE filed by Medicus Sciences Acquisition Corp.
- SEC Form SC 13G/A filed by Medicus Sciences Acquisition Corp. (Amendment)
- SEC Form SC 13G filed by Medicus Sciences Acquisition Corp.
- SEC Form SC 13G filed by Medicus Sciences Acquisition Corp.
- Medicus Sciences Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Medicus Sciences Acquisition Corp. Announces Liquidation
- Medicus Sciences Acquisition Corp. Announces Liquidation
Latest PNTM
- SEC Form SC 13G filed by Pontem Corporation
- SEC Form SC 13G/A filed by Pontem Corporation (Amendment)
- SEC Form 15-12G filed by Pontem Corporation
- SEC Form 25-NSE filed by Pontem Corporation
- Pontem Corporation Will Redeem Its Public Shares And Will Not Consummate An Initial Business Combination; Redemption Price For The Public Shares Will Be ~$10.32
- Pontem Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Pontem Corporation will redeem its Public Shares and will not consummate an initial business combination
- SEC Form 10-Q filed by Pontem Corporation
- SEC Form 3 filed by new insider Hagen David
- Pontem Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits